In accordance with timing of CF administration, there were significantly higher transcripts of Acox1 and Cyp4a10 but no change in Ppara in CF-mothers and their offspring only at E18, but not during postnatal life, as compared to age-matched control peers. The gene discussed is ACOX1; the disease is cystic fibrosis.